Abstract:Objective: Vitamin D deficiency is associated with a range of skeleton and muscle disorders, including osteoporosis and sarcopenia, but its functional role and the underlying mechanism in skeleton and muscle physiology remain unclear. We investigated the effect of vitamin D receptor (VDR) deletion on skeleton and muscle using a mice model with dexamethasone-induced osteo-sarcopenia (OS). Methods: The wildtype and VDR(-/-) mice were treated with vehicle and dexamethasone (i.p., once daily) for 14 consecutive days. The murine myoblast cell line C2C12 and bone mesenchymal stem cells (BMSCs) were used as an in vitro model in this study. Results: After challenging to dexamethasone, VDR-null mice exhibited more severe amyotrophy and bone rarefaction compared with wildtype counterparts, manifested by marked weight loss and significant decrease in muscle wet weight coefficient of the tibialis anterior muscle and gastrocnemius, accompanying with a decrease in bone mineral density (BMD). In addition, the limb grip and weight-loading swimming time were also fall off. Similarly, dystrophin fluorescence staining and haematoxylin eosin staining showed the decrease in cross-sectional area of skeletal muscle in the VDR-null mice. Alizarin red staining and TRAP staining showed that the differentiation of osteoblasts was significantly decreased, while the activity of osteoclasts was significantly increased in the VDR-null mice. VDR knockout mice significantly accelerated protein degradation and bone destructions, but inhibited protein synthesis and bone construction in skeleton and muscle tissue. In addition, we further assessed whether increased Fe2+ level and decreased GPX4 in VDR knockout muscle accelerated the muscle injury, since the deletion of VDR activated ferroptosis, giving rise to the accumulated of Fe2+ in mice and Depleting GSH and inhibiting GPX4 expression. Treatment with the inhibitor of ferroptosis Ferrostatin-1 eliminated dexamethasone-induced atrophy and osteoporosis of myotube cells and BMSCs, reflected by alleviating myotube cell atrophy and BMSCs bone rarefaction via MHC fluorescent staining, Alizarin red staining and TRAP staining. It is suggested that ferroptosis may be one of the pathogenesis of OS. Conclusion: These results provided evidence that VDR attenuated dexamethasone-induced OS at least in part by suppressing the ferroptosis. This work was sponsored by the Program of Natural Science Foundation of China (81973889), the Program of Shaanxi Education Department (19JC013 to FY & 22JK0346 to WL), Youth Innovation Team in Shaanxi universities, and the Program of Health Commission of Shaanxi Province (2022B002). This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence

Exosomes Derived from Vascular Endothelial Cells Antagonize Glucocorticoid-Induced Osteoporosis by Inhibiting Ferritinophagy with Resultant Limited Ferroptosis of Osteoblasts.

Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head

Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis

Dimethyloxalylglycine Attenuates Steroid-Associated Endothelial Progenitor Cell Impairment and Osteonecrosis of the Femoral Head by Regulating the HIF-1α Signaling Pathway

Extracorporeal shockwave relieves endothelial injury and dysfunction in steroid-induced osteonecrosis of the femoral head via miR-135b targeting FOXO1: in vitro and in vivo studies

sEV-mediated Lipid Droplets Transferred from Bone Marrow Adipocytes promote ferroptosis and impair Osteoblast Function

Vitamin D Receptor Attenuates Osteo-sarcopenia by Suppressing the Ferroptosis

Melatonin Inhibits the Ferroptotic Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K-AKT-mTOR Signaling Axis to Attenuate Steroid-induced Osteoporosis

Iron overload‐induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: an in vitro and in vivo study

Therapeutic Effects of Mechanical Stress-Induced C2C12-Derived Exosomes on Glucocorticoid-Induced Osteoporosis Through miR-92a-3p/PTEN/AKT Signaling Pathway

Melatonin Inhibits the Ferroptosis Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K/AKT/mTOR Signaling Axis to Attenuate Steroid-Induced Osteoporosis

DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis

Beneficial Effect of Grape Seed Proanthocyanidin Extract in Rabbits with Steroid-Induced Osteonecrosis Via Protecting Against Oxidative Stress and Apoptosis.

Exosomes derived from Wharton's jelly of human umbilical cord mesenchymal stem cells reduce osteocyte apoptosis in glucocorticoid-induced osteonecrosis of the femoral head in rats via the miR-21-PTEN-AKT signalling pathway

Dendrobium offificinale polysaccharides prevents glucocorticoids-induced osteoporosis by destabilizing KEAP1-NRF2 interaction

Delay the progression of glucocorticoid-induced osteoporosis: Fraxin targets ferroptosis via the Nrf2/GPX4 pathway

Extracellular Vesicles from Human Urine-Derived Stem Cells Inhibit Glucocorticoid-Induced Osteonecrosis of the Femoral Head by Transporting and Releasing Pro-Angiogenic DMBT1 and Anti-Apoptotic TIMP1.

Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhacning autophagy

Preliminary study on the mechanism by which exosomes derived from human exfoliated deciduous teeth improve the proliferation and osteogenic inhibitory effect of glucocorticoid-induced BMSCs

Polycytosine RNA-binding protein 1 regulates osteoblast function via a ferroptosis pathway in type 2 diabetic osteoporosis